Back
Phio Pharmaceuticals Vs. Pyxis Oncology Industry Stock Comparison
Sell
33
PHIO
Phio Pharmaceuticals
Last Price:
0.75
Seasonality Move:
-10.99%
Sell
18
PYXS
Pyxis Oncology
Last Price:
3.75
Seasonality Move:
-9.87%
Sell
33
Phio Pharmaceuticals (PHIO)
is a Sell
Is Phio Pharmaceuticals a Buy, Sell or Hold?
- The current Phio Pharmaceuticals [PHIO] share price is $0.75. The Score for PHIO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- PHIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
Pyxis Oncology (PYXS)
is a Sell
Is Pyxis Oncology a Buy, Sell or Hold?
- The current Pyxis Oncology [PYXS] share price is $3.74. The Score for PYXS is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- PYXS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
PHIO Stock Price Chart
What is Phio Pharmaceuticals's stock price today?
-
The Phio Pharmaceuticals share price today is $0.75
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
PYXS Stock Price Chart
What is Pyxis Oncology's stock price today?
-
The Pyxis Oncology share price today is $3.74
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PYXS is experiencing selling pressure, which indicates risk of future bearish movement.
PHIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 49.1 | Sell |
| Chaikin Money Flow: | 29487 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.71 - 0.81) | Sell |
| Bollinger Bands (100): | (0.63 - 0.87) | Sell |
PYXS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 33.73 | Sell |
| Chaikin Money Flow: | -147783 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.91 - 4.41) | Sell |
| Bollinger Bands (100): | (3.41 - 5.45) | Sell |
PHIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.76 | Sell |
| 20-day SMA: | 0.77 | Sell |
| 50-day SMA: | 0.73 | Buy |
| 200-day SMA: | 1.07 | Sell |
| 8-day EMA: | 0.76 | Sell |
| 20-day EMA: | 0.76 | Sell |
| 50-day EMA: | 0.76 | Sell |
| 200-day EMA: | 1.43 | Sell |
PYXS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.82 | Sell |
| 20-day SMA: | 4.1 | Sell |
| 50-day SMA: | 4.44 | Sell |
| 200-day SMA: | 3.14 | Buy |
| 8-day EMA: | 3.84 | Sell |
| 20-day EMA: | 4.05 | Sell |
| 50-day EMA: | 4.3 | Sell |
| 200-day EMA: | 3.63 | Buy |
Phio Pharmaceuticals Earnings Growth & PHIO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Pyxis Oncology Earnings Growth & PYXS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.07 per share, an increase this year of $0.91 per share, and a decrease next year of $0.25 per share.
Phio Pharmaceuticals Technical Analysis
| May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Pyxis Oncology Technical Analysis
| May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||